| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689890 | Kidney International Reports | 2017 | 8 Pages |
Abstract
QPI-1002 was rapidly eliminated from plasma. QPI-1002 was safe and well tolerated across all dose groups. Overall, no dose-limiting toxicities or safety signals were observed in the study. Further development of QPI-1002 for prophylaxis of acute kidney injury is warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Segav Demirjian, Gorav Ailawadi, Martin Polinsky, Dani Bitran, Shuli Silberman, Stanton Keith Shernan, Michel Burnier, Marta Hamilton, Elizabeth Squiers, Shai Erlich, Daniel Rothenstein, Samina Khan, Lakhmir S. Chawla,